FDA’s Breakthrough Designation Now Includes Health Equity Provision
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
From - Diagnostic Testing & Emerging Technologies
While few direct-to-consumer (DTC) genetic testing consumers share their results with a health care provider, most who do are satisfied with the discussion of results…
From - Diagnostic Testing & Emerging Technologies
A new survey reveals that laboratories are planning to increase equipment purchases this year, with analytical instrumentation reported…
From - Diagnostic Testing & Emerging Technologies
Communicating genetic risk of disease estimates does not impact individuals' health related behaviors, according to a review published March 15 in the…
From - Diagnostic Testing & Emerging Technologies
A new breast cancer staging system adds HER2 (ERBB2-positive disease) status to a list of factors used to assess prognosis in women who undergo neoadjuvant (pre-surgical) therapy for…